Biotech

All Articles

Orion to utilize Aitia's 'electronic identical twins' to locate new cancer medications

.Finnish biotech Orion has actually spied potential in Aitia's "electronic double" specialist to bui...

Windtree's surprise med brings up high blood pressure in most up-to-date period 2 gain

.While Windtree Therapeutics has had a hard time to develop the economic origins needed to have to s...

2 cancer cells biotechs merge, developing global footprint

.OncoC4 is taking AcroImmune-- as well as its internal clinical production functionalities-- under i...

Amgen records 1st stage 3 gain for $400M chronic eczema drug

.Amgen has actually shared (PDF) the very first phase 3 data on its $400 million chronic eczema medi...

Biogen, UCB file period 3 lupus win after stopping working earlier test

.Biogen and UCB's bet one's bottom dollar developing right into stage 3 astride an unsuccessful rese...

Aptadir wishes brand new RNA inhibitors may turn around difficult cancers cells

.Italian biotech Aptadir Therapeutics has released with the assurance that its pipeline of preclinic...

Wave surfs DMD results to regulatory authorities' doors, sending stockpile

.Wave Life Sciences has actually satisfied its own goal in a Duchenne muscular dystrophy (DMD) resea...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma crea...

Achilles trickles cell treatment program, braces for layoffs after missing 'office viability' goals

.Achilles Therapies has actually shreded its strategy. The British biotech is actually quiting worki...

Aligos declares period 2 MASH succeed, lowering liver excess fat approximately 46%

.Aligos Therapies is actually declaring a midstage gain in metabolic-dysfunction associated steatohe...